Pharmacodynamic interaction between the new selective cholesterol absorption inhibitor ezetimibe and simvastatin

AIMS: The primary aims of these two single-centre, randomized, evaluator-blind, placebo/positive-controlled, parallel-group studies were to evaluate the potential for pharmacodynamic and pharmacokinetic interaction between ezetimibe 0.25, 1, or 10 mg and simvastatin 10 mg (Study 1), and a pharmacody...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kosoglou, Teddy, Meyer, Ingo, Veltri, Enrico P, Statkevich, Paul, Yang, Bo, Zhu, Yali, Mellars, Lillian, Maxwell, Stephen E, Patrick, James E, Cutler, David L, Batra, Vijay K, Affrime, Melton B
Format: Artigo
Langue:Inglês
Publié: Blackwell Science Inc 2002
Sujets:
Drugs Interaction
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1874429/
https://ncbi.nlm.nih.gov/pubmed/12236852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1046/j.1365-2125.2002.01633.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires